Free Trial

Life Science REIT (LABS) Stock Forecast & Price Target

Life Science REIT logo
GBX 39.10 +0.70 (+1.82%)
As of 09/5/2025 11:57 AM Eastern

Life Science REIT - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
0
Buy
2

Based on 2 Wall Street analysts who have issued ratings for Life Science REIT in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 2 have given a buy rating for LABS.

Consensus Price Target

GBX 57
According to the 2 analysts' twelve-month price targets for Life Science REIT, the average price target is GBX 57. The highest price target for LABS is GBX 57, while the lowest price target for LABS is GBX 57. The average price target represents a forecasted upside of 45.78% from the current price of GBX 39.10.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LABS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Life Science REIT and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LABS Analyst Ratings Over Time

TypeCurrent Forecast
9/7/24 to 9/7/25
1 Month Ago
8/8/24 to 8/8/25
3 Months Ago
6/9/24 to 6/9/25
1 Year Ago
9/8/23 to 9/7/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 57GBX 46.50GBX 46.50GBX 57.50
Consensus RatingBuyModerate BuyModerate BuyModerate Buy

LABS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LABS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Life Science REIT Stock vs. The Competition

TypeLife Science REITReal Estate Companies
Consensus Rating Score
3.00
2.67
Consensus RatingBuyModerate Buy
News Sentiment Rating
Neutral News

See Recent LABS News
Neutral News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/3/2024Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuyGBX 57+43.90%
9/26/2024Shore Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
8/30/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetHoldGBX 45 ➝ GBX 36+6.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 07:23 AM ET.


LABS Forecast - Frequently Asked Questions

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Life Science REIT is GBX 57, with a high forecast of GBX 57 and a low forecast of GBX 57.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LABS shares.

According to analysts, Life Science REIT's stock has a predicted upside of 45.78% based on their 12-month stock forecasts.

Analysts like Life Science REIT more than other "real estate" companies. The consensus rating for Life Science REIT is Buy while the average consensus rating for "real estate" companies is Moderate Buy. Learn more on how LABS compares to other companies.


This page (LON:LABS) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners